All News
Antimicrobial Resistance
Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem.
Read MoreVutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy
(MedPage Today) -- Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded
Read More'Leaning In' to a Fresh Start in Residency
(MedPage Today) -- Welcome to MedPage Today's "White Coat Chronicles," a short-form feature series where we follow Emilie "Mia" Mathura, DO, MSPH, during her first year of residency in ob/gyn.
Read MoreAlnylam enters the ATTR-CM drug race
Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.
Read MoreNewer Biologics Tied to Fewer Infections for Older Patients With Psoriatic Disease
(MedPage Today) -- Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a Canadian cohort study
Read MorePrescription Drug User Fee Amendments
The Prescription Drug User Fee Act (PDUFA) was created by Congress in 1992 and authorizes FDA to collect fees from companies that produce certain human drug and biological products.
Read MoreHealth Agencies Remain in the Dark About Next Round of Firings
(MedPage Today) -- A week has passed since federal agency leaders were supposed to submit plans for reductions-in-force (RIFs) and agency reorganizations, but workers at federal health agencies have
Read MoreGeneric Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.
Read More